A phase 3 study comparing tenofovir alafenamide (TAF) to tenofovir disoproxil fumarate (TDF) in patients with HBeAg-positive, chronic hepatitis B (CHB): efficacy and safety results at week 96
作者
Kosh Agarwal,Scott K. Fung,Wai‐Kay Seto,Young‐Suk Lim,Edward John Gane,H.L.A. Janssen,Mithun Sharma,Wan‐Long Chuang,H. Bae,K.T. Yoon,J.F. Flaherty,Audrey H. Lau,Anuj Gaggar,Vithika Suri,A. Cathcart,L. Lin,G. Mani Subramanian,S. Shalimar,Norihiro Furusyo,Marı́a Buti